Who
Ramy Farid
Director
Company insider
Files Form 4 as: Director, Vir Biotechnology; President & CEO, Schrodinger; Director, Structure Therapeutics.
In numbers
- Trades disclosed
- 63
- Buys
- 0
- Sells
- 8
- Bought
- $0
- Sold
- $13.5M
- Companies
- 3
- Companies where not an officer
- 2
- First trade
- 10 Feb 2020
- Last trade
- 27 May 2026
- Last filed
- 28 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 27 May 2026filed 28 May 2026 | VIR Vir BiotechnologyBiotechnology | SEC FORM 4 Code A | —8,000 at $0.00 | filing |
| 27 May 2026filed 28 May 2026 | VIR Vir Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,000 at $0.00 | filing |
| 27 May 2026filed 28 May 2026 | VIR Vir Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,000 at $0.00 | filing |
| 27 May 2026filed 28 May 2026 | VIR Vir BiotechnologyBiotechnology | SEC FORM 4 Code A | —8,000 at $0.00 | filing |
| 17 Apr 2026filed 17 Apr 2026 | SDGR SchrodingerLife-science tools | SEC FORM 4 Code M | $132K43,000 at $3.07 | filing |
| 17 Apr 2026filed 17 Apr 2026 | SDGR Schrodingeroption or derivative · Life-science tools | SEC FORM 4 Code M | —43,000 at $0.00 | filing |
| 17 Apr 2026filed 17 Apr 2026 | SDGR Schrodingeroption or derivative · Life-science tools | SEC FORM 4 Code M | —74,527 at $0.00 | filing |
| 17 Apr 2026filed 17 Apr 2026 | SDGR SchrodingerLife-science tools | SEC FORM 4 Sold | $525K43,000 at $12.21 | filing |
| 17 Apr 2026filed 17 Apr 2026 | SDGR SchrodingerLife-science tools | SEC FORM 4 Code M | $229K74,527 at $3.07 | filing |
| 17 Apr 2026filed 17 Apr 2026 | SDGR Schrodingeroption or derivative · Life-science tools | SEC FORM 4 Code M | —43,000 at $0.00 | filing |
| 17 Apr 2026filed 17 Apr 2026 | SDGR Schrodingeroption or derivative · Life-science tools | SEC FORM 4 Code M | —74,527 at $0.00 | filing |
| 17 Apr 2026filed 17 Apr 2026 | SDGR SchrodingerLife-science tools | SEC FORM 4 Code M | $132K43,000 at $3.07 | filing |
| 17 Apr 2026filed 17 Apr 2026 | SDGR SchrodingerLife-science tools | SEC FORM 4 Sold | $525K43,000 at $12.21 | filing |
| 17 Apr 2026filed 17 Apr 2026 | SDGR SchrodingerLife-science tools | SEC FORM 4 Code M | $229K74,527 at $3.07 | filing |
| 16 Apr 2026filed 17 Apr 2026 | SDGR SchrodingerLife-science tools | SEC FORM 4 Code M | $132K43,000 at $3.07 | filing |
| 16 Apr 2026filed 17 Apr 2026 | SDGR SchrodingerLife-science tools | SEC FORM 4 Sold | $530K43,000 at $12.33 | filing |
| 16 Apr 2026filed 17 Apr 2026 | SDGR Schrodingeroption or derivative · Life-science tools | SEC FORM 4 Code M | —43,000 at $0.00 | filing |
| 16 Apr 2026filed 17 Apr 2026 | SDGR Schrodingeroption or derivative · Life-science tools | SEC FORM 4 Code M | —43,000 at $0.00 | filing |
| 16 Apr 2026filed 17 Apr 2026 | SDGR SchrodingerLife-science tools | SEC FORM 4 Code M | $132K43,000 at $3.07 | filing |
| 16 Apr 2026filed 17 Apr 2026 | SDGR SchrodingerLife-science tools | SEC FORM 4 Sold | $530K43,000 at $12.33 | filing |
News
Claritev (NYSE:CTEV) and Schrodinger (NASDAQ:SDGR) Financial SurveySDGR · dailypolitical.com · 19 Oct 2026Head to Head Review: Schrodinger (NASDAQ:SDGR) versus VSee Health (NASDAQ:VSEE)SDGR · tickerreport.com · 14 Oct 2026
0 headlines in the last 90 days name Ramy Farid; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.